RHUDEX

Dead / Cancelled — Cancelled — Section 8 (as of 29 Nov 2019)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
85362627
Registration number
4322812
Mark type
Stylized text
Filed
04 Jul 2011
Published for opposition
17 Jul 2012
Registered
23 Apr 2013
Attorney of record
David A. Bell

Goods and services

  • Class 005 — Pharmaceuticals: Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, and CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics; pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
  • Class 010 — Medical apparatus: Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors and syringes
  • Class 042 — Scientific and technological services: Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property, namely, trademarks and patents in the field of biotechnology

Owner

Prior registrations

Prosecution history

  • 29 Nov 2019 — CANCELLED SEC. 8 (6-YR)
  • 23 Apr 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 23 Apr 2013 — REGISTERED-PRINCIPAL REGISTER
  • 18 Mar 2013 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
  • 05 Mar 2013 — NOTICE OF ALLOWANCE CANCELLED
  • 11 Mar 2013 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 05 Mar 2013 — TEAS DELETE 1(B) BASIS RECEIVED
  • 11 Sept 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 17 Jul 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 17 Jul 2012 — PUBLISHED FOR OPPOSITION
  • 27 Jun 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 14 Jun 2012 — LAW OFFICE PUBLICATION REVIEW COMPLETED
  • 13 Jun 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 17 May 2012 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 17 May 2012 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy